An in-vitro evaluation of melatonin as a antibacterial agent on periodontal pathogens

Please use this identifier to cite or link to this item: http://172.16.16.104:8080/xmlui/handle/123456789/314

Full metadata record

DC Field	Value	Language
dc.contributor.author	Acharya2, Anirudh	-
dc.date.accessioned	2021-08-24T12:35:44Z	-
dc.date.available	2021-08-24T12:35:44Z	-
dc.date.issued	2018	-
dc.identifier.uri	http://172.16.16.104:8080/xmlui/handle/123456789/314	-
dc.description.abstract	Aim and Objectives: Periodontal disease is an inflammatory condition of the periodontium caused by the imbalance in host bacterial interaction. Various agents have been used as biomarkers in the pathogenesis of periodontal disease. Melatonin, an indole amine hormone secreted by pineal gland is one such hormone. Melatonin has been declared an ubiquitous molecule, exerting antibacterial effect against various antibiotic resistant strains of microorganisms. However its effect against periodontal pathogens is not yet clear. Hence this in vitro qualitative analysis was conducted to evaluate the antibacterial efficacy of melatonin on selected periodontal pathogens	en_US
dc.description.sponsorship	World Journal of Pharmaceutical and Life Sciences	en_US
dc.language.iso	en	en_US
dc.publisher	World Journal of Pharmaceutical and Life Sciences	en_US
dc.subject	Melatonin,	en_US
dc.subject	Periodontal pathogens,	en_US
dc.subject	Pineal gland,	en_US
dc.subject	Minimum inhibitory concentration	en_US
dc.title	An in-vitro evaluation of melatonin as a antibacterial agent on periodontal pathogens	en_US
dc.type	Article	en_US
Appears in Collections:	An in-vitro evaluation of melatonin as a antibacterial agent on periodontal pathogens

Files in This Item:

File	Description	Size	Format
An in-vitro evaluation of melatonin as a antibacterial agent on periodontal pathogens.pdf		359.86 kB	Adobe PDF	View/Open